De Raffele Emilio, Mirarchi Mariateresa, Caserta Carmelo Antonio, Cuicchi Dajana, Pendino Gaspare Maria, Lecce Ferdinando, Cariani Stefano, Cola Bruno
Ann Ital Chir. 2018;89:128-137.
Hepatocellular carcinoma (HCC) is one of the leading cancer in the world, susceptible to potentially curative liver resection (LR) in selected cases. Centrally located HCC (CL-HCC) are sited in central liver segments and may require complex LR because of their relationship to major vascular and biliary structures and deep parenchymal location. Even though extended segment-oriented resections are recommended for oncological reasons, more conservative LR may be indicated in patients with cirrhosis to preserve an adequate function of the future remnant liver (FRL). To extend the indication to LR and to increase the safety of the surgical procedure, preoperative portal vein embolization (PVE) or sequential transarterial embolization/chemoembolization (TAE/TACE) and PVE have been widely used, to induce atrophy of the embolized segments involved by the tumor and compensatory hypertrophy of the FLR. The most appropriate surgical strategy for small uninodular CL-HCC remains controversial, and should be decided according to the features of the tumor at preoperative imaging, the relationship with major intrahepatic vessels and the expected function of the FRL. We report here two cases of elderly cirrhotic patients with unifocal small CL-HCC, where the surgical strategy was decided according to the kind of relationship of the tumor with the hepatic hilum at preoperative imaging. In the first case there was no clear evidence of neoplastic infiltration of the hilar vessels, so that a minor conservative LR was preferred. In the second patient the tumor was suspected to infiltrate the right portal vein, and a major LR was performed after sequential TACE/PVE.
Centrally located, Future remnant liver, Hepatocellular carcinoma, Liver cirrhosis, Liver resection, Portal vein embolization, Transarterial chemoembolization.
肝细胞癌(HCC)是全球主要癌症之一,部分病例适合进行可能治愈性的肝切除术(LR)。中央型肝细胞癌(CL-HCC)位于肝脏中央段,由于其与主要血管和胆管结构的关系以及实质深部位置,可能需要复杂的肝切除术。尽管出于肿瘤学原因推荐进行扩大的段切除术,但对于肝硬化患者,可能需要更保守的肝切除术以保留未来残余肝(FRL)的足够功能。为了扩大肝切除术的适应证并提高手术安全性,术前门静脉栓塞(PVE)或序贯经动脉栓塞/化疗栓塞(TAE/TACE)联合PVE已被广泛应用,以诱导肿瘤累及的栓塞段萎缩和FRL的代偿性肥大。对于小的单结节CL-HCC,最合适的手术策略仍存在争议,应根据术前影像学检查的肿瘤特征、与主要肝内血管的关系以及FRL的预期功能来决定。我们在此报告两例老年肝硬化患者的单灶性小CL-HCC病例,其手术策略根据术前影像学检查中肿瘤与肝门的关系类型来决定。第一例患者没有明确的肝门血管肿瘤浸润证据,因此选择了较小的保守性肝切除术。第二例患者怀疑肿瘤浸润右门静脉,在序贯TACE/PVE后进行了扩大的肝切除术。
中央型;未来残余肝;肝细胞癌;肝硬化;肝切除术;门静脉栓塞;经动脉化疗栓塞